Eyad ALMOUAZEN
20
Documents
Présentation
**Sep 2014 – Present Associated Professor**
University Lyon 1
Teaching at **Faculty of Pharmacy ISPB**, Pharmaceutical and Cosmetic Technology Department
Research at **LAGEP‐** **UMR CNRS 5007 – Pharmaceutical Engineering Team**
Design and development of innovative dosage forms for therapeutic applications: working on the elaboration of pharmaceutical formulations, the development of required analytical methods and the needed biological evaluations.
Main projects:
- Development of antigen nanoparticles as a vaccine for veterinary applications.
- Investigation of the therapeutic effects of nanoencapsulated vitamin D3.
- Development of the polymeric nanoparticles for targeting immunity
- Use of nano-encapsulated haptens to improve the performance of skin sensitization non-animal Innovative Drug Delivery Strategies
**2012 – 2014 Temporary Assistant Professor**
Faculty of Pharmacy ISPB, University Lyon 1, France
Research: oral vaccine development for veterinary application
**2009 – 2013 PhD student in Pharmaceutical Technology**
LAGEP UMR CNRS 5007 and INSERM U1028, University Lyon1, France
Thesis title: Development of polymeric nanoparticles for targeting and modulating macrophage functions.
-Retinoic acid and vitamin D3 encapsulation by nanoprecipitation
-Evaluation of nanoparticle uptake by macrophages in vitro and in vivo
-Assessment of therapeutical potential of developed nanoparticles
**Feb – July 2009 MSc Research internship**
LAGEP UMR CNRS 5007 and INSERM U851, University Lyon1, France
Project title: Use of nano-encapsulated haptens to improve the performance of skin sensitization non-animal test.
-Elaboration of hapten loaded polymeric nanoparticle.
-Test of nanoparticles on dendritic cells – T-cells co-culture.
**Mar – Sep 2008 Formulation Engineer**
Laboratory of skin care development, L’Oreal-Paris, Chevilly-Larue, France
Project title: New formulation development for cleansing application.
-Formulation and stability study of low viscosity emulsions.
**Jan – Juin 2007 R&D Engineer**
Expanscience Laboratories, Damascus, Syria
-Performed new control methods
-Validation of quality control protocols.
Publications
Nanoparticles and macrophages enhance anticancer activity of vitamin D3 metabolites9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 2014, Lisbone, Portugal
Communication dans un congrès
hal-02013719v1
|
|
Development of nanoparticle delivery system for oral vaccination of dogsParavac Meeting, 2014, Cordoba, Spain
Communication dans un congrès
hal-01958034v1
|
|
Développement de nanoparticules polymères pour le ciblage et la modulation des macrophagesJOURNÉE LYONNAISE AGENTS D’IMAGERIE " Nanoparticules multimodales pour le diagnostic et la thérapie, 2013, Lyon, France
Communication dans un congrès
hal-01958037v1
|
|
Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 2012, Istanbul, Turkey
Communication dans un congrès
hal-01958045v1
|
|
Development of 25-hydroxyvitamin D3 nanoparticles for application in chemotherapy: formulation study8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 2012, Istanbul, Turkey
Communication dans un congrès
hal-01958046v1
|
|
Development of polymeric nanoparticles for targeting and modulating macrophage functions17ème Journée scientifique de l’EDISS, 2012, Lyon, France
Communication dans un congrès
hal-01958047v1
|
|
Development of polymeric nanoparticles for targeting and modulating macrophage functions16ème Journée scientifique de l’EDISS, 2011, Lyon, France
Communication dans un congrès
hal-01958057v1
|
|
Development of polymeric nanoparticles for modulating macrophage functions2nd Conference Innovation in Drug Delivery:From preformulation to development through innovative evaluation process, 2010, Aix en Provence, France
Communication dans un congrès
hal-01958063v1
|
|
Development of polymeric nanoparticles for modulating macrophage functions: an original strategy of cellular therapy for autoimmune diseases7th world meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 2010, Unknown, Malta
Communication dans un congrès
hal-01958066v1
|
|
Développement de nanoparticules polymères pour le ciblage des macrophages et la modulation des leurs fonctions physiologiquesMédecine humaine et pathologie. Université Claude Bernard - Lyon I, 2013. Français. ⟨NNT : 2013LYO10121⟩
Thèse
tel-00945306v1
|